Alimentary Tract| Volume 54, ISSUE 6, P763-770, June 2022

Download started.


The value of multi-modes of ultrasound in evaluating segmental mucosal healing in patients with Crohn's disease

Published:January 03, 2022DOI:



      Mucosal healing, the result of endoscopic remission, is associated with prolonged clinical remission and delayed deterioration of Crohn's disease, which is significant and accompanied by reduced hospitalizations and surgeries. Currently, the relationship between ultrasonic parameters and mucosal healing remains controversial. To establish an ultrasonic regression model to evaluate mucosal healing, we conducted this preliminary study using multiple parameters from B-mode ultrasonography, colour Doppler flow imaging and shear wave elastography systematically.


      This study consisted of two single-centre investigations based on development and validation populations who received endoscopies (as the gold standard) and ultrasound. The involved bowel segments were divided into mucosal healing (MH) and nonmucosal healing (NMH) groups according to endoscopic results. Eight ultrasonic parameters were observed, including bowel wall thickness (BWT), mesenteric fat thickness (MFT), median modulus of elasticity (Emean), average shear wave velocity (SWV), Limberg scoring (LG), bowel wall stratification (BWS), ascites (AS) and lymph node enlargement (LN). We developed an ultrasonic regression model in the development phase to evaluate segmental mucosal healing and undertook prospective validation of this model.


      A total of 124 patients with 380 involved bowel segments from the development and validation cohorts were evaluated. Eight ultrasonic parameters were significantly different between the two groups (P<0.05) in the development phase. Four significant parameters with better AUC performance were selected to establish an ultrasonic regression model to predict mucosal healing. The AUCs of this ultrasonic model were 0.975 and 0.942 in the development and validation cohorts, respectively.


      The multimodal ultrasonic model has the potential to evaluate segmental mucosal healing in Crohn's disease.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Feuerstein J.D.
        • Cheifetz A.S.
        Crohn Disease: Epidemiology, Diagnosis, and Management.
        Mayo Clin Proc. 2017; 92: 1088-1103
        • Cosnes J.
        • Cattan S.
        • Blain A.
        • et al.
        Long-term evolution of disease behavior of Crohn's disease.
        Inflamm Bowel Dis. 2002; 8: 244-250
        • De Cruz P.
        • Kamm M.A.
        • Prideaux L.
        • Allen P.B.
        • Moore G.
        Mucosal healing in Crohn's disease: a systematic review.
        Inflamm Bowel Dis. 2013; 19: 429-444
        • Greenberg G.R.
        • Feagan B.G.
        • Martin F.
        • et al.
        Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group.
        Gastroenterology. 1996; 110: 45-51
        • Shah S.C.
        • Colombel J.F.
        • Sands B.E.
        • Narula N.
        Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.
        Aliment Pharmacol Ther. 2016; 43: 317-333
        • Cucchiara S.
        • D'Arcangelo G.
        • Isoldi S.
        • Aloi M.
        • Stronati L.
        Mucosal healing in Crohn's disease: new insights.
        Expert Rev Gastroenterol Hepatol. 2020; 14: 335-345
        • Peyrin-Biroulet L.
        • Sandborn W.
        • Sands B.E.
        • et al.
        Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
        Am J Gastroenterol. 2015; 110: 1324-1338
        • Turner D.
        • Ricciuto A.
        • Lewis A.
        • et al.
        STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
        Gastroenterology. 2021; 160: 1570-1583
        • Baert F.
        • Moortgat L.
        • Van Assche G.
        • et al.
        Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease.
        Gastroenterology. 2010; 138 (quiz e10-1): 463-468
        • Rutgeerts P.
        • Van Assche G.
        • Sandborn W.J.
        • et al.
        Adalimumab induces and maintains mucosal healing in patients with Crohn’s disease: data from the EXTEND trial.
        Gastroenterology. 2012; 142 (e2): 1102-1111
        • Schnitzler F.
        • Fidder H.
        • Ferrante M.
        • et al.
        Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.
        Inflamm Bowel Dis. 2009; 15: 1295-1301
        • Rutgeerts P.
        • Diamond R.H.
        • Bala M.
        • et al.
        Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
        Gastrointest Endosc. 2006; 63 (quiz 464): 433-442
        • Lichtenstein G.R.
        • Loftus E.V.
        • Isaacs K.L.
        • Regueiro M.D.
        • Gerson L.B.
        • Sands B.E.
        ACG Clinical Guideline: Management of Crohn's Disease in Adults.
        Am J Gastroenterol. 2018; 113: 481-517
        • Feagan B.G.
        • Lémann M.
        • Befrits R.
        • et al.
        Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report.
        Inflamm Bowel Dis. 2012; 18: 152-160
        • Solem C.A.
        • Loftus Jr, E.V.
        • Tremaine W.J.
        • Harmsen W.S.
        • Zinsmeister A.R.
        • Sandborn W.J.
        Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
        Inflamm Bowel Dis. 2005; 11: 707-712
        • Mitselos I.V.
        • Christodoulou D.K.
        • Katsanos K.H.
        • Tsianos E.V.
        Role of wireless capsule endoscopy in the follow-up of inflammatory bowel disease.
        World J Gastrointest Endosc. 2015; 7: 643-651
        • Bruining D.H.
        • Loftus Jr, E.V.
        • Ehman E.C.
        • et al.
        Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease.
        Clin Gastroenterol Hepatol. 2011; 9 (e1): 679-683
        • Rimola J.
        • Ordás I.
        • Rodriguez S.
        • et al.
        Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.
        Inflamm Bowel Dis. 2011; 17: 1759-1768
        • Dulai P.S.
        • Levesque B.G.
        • Feagan B.G.
        • D'Haens G.
        • Sandborn W.J.
        Assessment of mucosal healing in inflammatory bowel disease: review.
        Gastrointest Endosc. 2015; 82: 246-255
        • Castiglione F.
        • Testa A.
        • Rea M.
        • et al.
        Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics.
        Inflamm Bowel Dis. 2013; 19: 1928-1934
        • Danese S.
        • Sandborn W.J.
        • Colombel J.F.
        • et al.
        Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn’s Disease.
        Gastroenterology. 2019; 157 (e7): 1007-1018
        • Satsangi J.
        • Silverberg M.S.
        • Vermeire S.
        • Colombel J.F.
        The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.
        Gut. 2006; 55: 749-753
        • Klenske E.
        • Bojarski C.
        • Waldner M.
        • Rath T.
        • Neurath M.F.
        • Atreya R.
        Targeting mucosal healing in Crohn's disease: what the clinician needs to know.
        Therap Adv Gastroenterol. 2019; 121756284819856865
        • Kucharzik T.
        • Wittig B.M.
        • Helwig U.
        • et al.
        Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.
        Clin Gastroenterol Hepatol. 2017; 15 (e2): 535-542
        • Liu C.
        • Ding S.S.
        • Zhang K.
        • et al.
        Correlation between ultrasound consolidated score and simple endoscopic score for determining the activity of Crohn's disease.
        Br J Radiol. 2020; 9320190614
        • Daperno M.
        • D'Haens G.
        • Van Assche G.
        • et al.
        Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
        Gastrointest Endosc. 2004; 60: 505-512
        • Neurath M.F.
        • Travis S.P.
        Mucosal healing in inflammatory bowel diseases: a systematic review.
        Gut. 2012; 61: 1619-1635
        • Maaser C.
        • Sturm A.
        • Vavricka S.R.
        • et al.
        ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.
        J Crohns Colitis. 2019; 13: 144-164
        • Kumar S.
        • Hakim A.
        • Alexakis C.
        • et al.
        Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn's disease: correlation with intraoperative findings and magnetic resonance enterography.
        J Gastroenterol Hepatol. 2015; 30: 86-91
        • Gulani V.
        • Calamante F.
        • Shellock F.G.
        • Kanal E.
        • Reeder S.B.
        • International Society for Magnetic Resonance in Medicine
        Gadolinium deposition in the brain: summary of evidence and recommendations.
        Lancet Neurol. 2017; 16: 564-570
        • Fraquelli M.
        • Castiglione F.
        • Calabrese E.
        • Maconi G.
        Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice.
        Dig Liver Dis. 2020; 52: 9-18
        • Yuksel I.
        • Kilincalp S.
        • Coskun Y.
        • Akinci H.
        • Hamamci M.
        • Alkan A.
        Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.
        Eur J Gastroenterol Hepatol. 2019; 31: 809-816
        • Panes J.
        • Bouhnik Y.
        • Reinisch W.
        • et al.
        Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.
        J Crohns Colitis. 2013; 7: 556-585
        • Panés J.
        • Bouzas R.
        • Chaparro M.
        • et al.
        Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.
        Aliment Pharmacol Ther. 2011; 34: 125-145
        • Castiglione F.
        • Mainenti P.
        • Testa A.
        • et al.
        Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents.
        Dig Liver Dis. 2017; 49: 484-489
        • Nardone O.M.
        • Rispo A.
        • Castiglione F.
        Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era.
        Dig Liver Dis. 2020; 52: 1236-1237
        • Carvalho P.B.
        • Rosa B.
        • Cotter J.
        Mucosal healing in Crohn's disease - are we reaching as far as possible with capsule endoscopy.
        J Crohns Colitis. 2014; 8: 1566-1567
        • Mary J.Y.
        • Modigliani R.
        Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).
        Gut. 1989; 30: 983-989
        • Novak K.L.
        • Kaplan G.G.
        • Panaccione R.
        • et al.
        A Simple Ultrasound Score for the Accurate Detection of Inflammatory Activity in Crohn's Disease.
        Inflamm Bowel Dis. 2017; 23: 2001-2010
        • Rimola J.
        • Rodriguez S.
        • García-Bosch O.
        • et al.
        Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease.
        Gut. 2009; 58: 1113-1120
        • Aibe T.
        • Fuji T.
        • Okita K.
        • Takemoto T.
        A fundamental study of normal layer structure of the gastrointestinal wall visualized by endoscopic ultrasonography.
        Scand J Gastroenterol Suppl. 1986; 123: 6-15
        • Paredes J.M.
        • Ripollés T.
        • Cortés X.
        • et al.
        Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease.
        Dig Dis Sci. 2010; 55: 404-410
        • Bots S.
        • Nylund K.
        • Löwenberg M.
        • Gecse K.
        • Gilja O.H.
        • D'Haens G.
        Ultrasound for Assessing Disease Activity in IBD Patients: A Systematic Review of Activity Scores.
        J Crohns Colitis. 2018; 12: 920-929
        • Dong J.
        • Wang H.
        • Zhao J.
        • et al.
        Ultrasound as a diagnostic tool in detecting active Crohn's disease: a meta-analysis of prospective studies.
        Eur Radiol. 2014; 24: 26-33
        • Fraquelli M.
        • Colli A.
        • Casazza G.
        • et al.
        Role of US in detection of Crohn disease: meta-analysis.
        Radiology. 2005; 236: 95-101
        • Ripollés T.
        • Paredes J.M.
        • Martínez-Pérez M.J.
        • et al.
        Ultrasonographic Changes at 12 Weeks of Anti-TNF Drugs Predict 1-year Sonographic Response and Clinical Outcome in Crohn's Disease: A Multicenter Study.
        Inflamm Bowel Dis. 2016; 22: 2465-2473
        • Maconi G.
        • Nylund K.
        • Ripolles T.
        • et al.
        EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases.
        Ultraschall Med. 2018; 39: 304-317
        • Ripollés T.
        • Martínez-Pérez M.J.
        • Paredes J.M.
        • Vizuete J.
        • Martin G.
        The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn's Disease Activity: Is Contrast Agent Injection Necessary.
        J Crohns Colitis. 2019; 13: 585-592
        • Ripollés T.
        • Martínez M.J.
        • Paredes J.M.
        • Blanc E.
        • Flors L.
        • Delgado F.
        Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy.
        Radiology. 2009; 253: 241-248
        • Peyrin-Biroulet L.
        • Chamaillard M.
        • Gonzalez F.
        • et al.
        Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander.
        Gut. 2007; 56: 577-583
        • Sampietro G.M.
        • Maconi G.
        • Colombo F.
        • et al.
        Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease.
        Dig Liver Dis. 2021;
        • Fernandes S.R.
        • Rodrigues R.V.
        • Bernardo S.
        • et al.
        Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease.
        Inflamm Bowel Dis. 2017; 23: 1403-1409
        • Ma L.
        • Li W.
        • Zhuang N.
        • et al.
        Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn's disease.
        Therap Adv Gastroenterol. 2021; 1417562848211016259
        • Goodsall T.M.
        • Jairath V.
        • Feagan B.G.
        • et al.
        Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease.
        Aliment Pharmacol Ther. 2021; 53: 873-886
        • Calabrese E.
        • Zorzi F.
        • Zuzzi S.
        • et al.
        Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease.
        J Crohns Colitis. 2012; 6: 852-860
        • Zorzi F.
        • Stasi E.
        • Bevivino G.
        • et al.
        A sonographic lesion index for Crohn's disease helps monitor changes in transmural bowel damage during therapy.
        Clin Gastroenterol Hepatol. 2014; 12: 2071-2077
        • Nylund K.
        • Maconi G.
        • Hollerweger A.
        • et al.
        EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound.
        Ultraschall Med. 2017; 38: e1-e15